ATCC and bioMérieux Collaborate to Deliver Accurate Identification of Industrial Microorganisms

ATCC and bioMérieux Collaborate to Deliver Accurate Identification of Industrial Microorganisms

Combined capabilities will enhance the accuracy and range of microbial identification for pharmaceutical, food, veterinary labs.

Durham, NC and Manassas, VA - August 21, 2014 - ATCC, the premier global biological materials resource and standards organization, and bioMérieux, a world leader in the field of in vitro diagnostics, announced today their collaboration to expand and solidify the bioMérieux VITEK® MS microbial identification database for the industrial market. Recently, ATCC acquired the bioMérieux VITEK® MS system to make this innovative MALDI TOF technology a fundamental component of their authentication and quality control processes.

Strengthening the database with additional strains continues to increase the robustness of the VITEK® MS micro-organisms library while increasing the size and enhancing the utility for customers as a solid quality assurance tool.

The integration of the bioMérieux VITEK® MS into ATCC’s quality development process will enable ATCC to generate a large pathogen knowledgebase, which will then be incorporated into the VITEK® MS database. The newly expanded database will improve the accuracy and range of microbial identification of the bioMérieux VITEK® MS, a powerful pathogen identification solution for large industrial labs.

“For more than eight decades, Microbiology laboratories worldwide have looked to ATCC to provide well characterized microbial reference strains with the highest level of quality assurance,” stated Kristina Peterman, Senior Director Compliance, Quality Assurance and Laboratory Testing Services/Chief Compliance Officer. “Utilizing the MALDI technology through the bioMérieux VITEK® MS system demonstrates our commitment to advancement, quality and innovation. The solution will also provide traceability and reduced testing time while reducing consumable costs in our extensive quality control process.”

“We are delighted to partner with ATCC, the recognized expert in industrial microbial identifications, said Pierre-Louis Thiney, Executive Director US Industry for bioMérieux. The partnership exemplifies both companies commitment to quality standards for our food, pharmaceutical and veterinary customers. It truly is a testament to the strong added value of our VITEK® MS solution.”

About ATCC

ATCC collaborates with and supports the scientific community with industry-standard products and innovative solutions. With the world’s largest and most diverse collection of human, animal, and plant cell lines, as well as microorganisms, molecular genomic tools, and biological products, ATCC is a trusted biological resource for the worldwide research community. Together, the people of ATCC share in its mission to acquire, authenticate, preserve, develop, and distribute biological materials and information for the advancement of scientific knowledge. Founded in 1925, ATCC is a non-profit organization with headquarters in Manassas, VA. Discover more at www.atcc.org.

ATCC contact

ATCC
Renée Randall
Tel: (703) 365-2773
Email: rrandall@atcc.org

About bioMérieux

Pioneering Diagnostics

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 41 subsidiaries and a  large  network  of  distributors.  In  2013,  revenues  reached  €1,588  million with 87% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the  source  of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM – ISIN: FR0010096479). Corporate website: www.biomerieux.com - Investor website: www.biomerieux-finance.com
 

Contacts
Media Relations